COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,044 Articles (22,627 medRxiv, 8,417 bioRxiv)

Most recent first Previous |  Page 2907: Articles 29061-29070  | Next

COVID-19 Critical Illness Pathophysiology Driven by Diffuse Pulmonary Thrombi and Pulmonary Endothelial Dysfunction Responsive to Thrombolysis
Poor, H. D., Ventetuolo, C. E., Tolbert, T., Chun, G., Serrao, G., Zeidman, A., Dangayach, N. S., Olin, J., Kohli-Seth, R., Powell, C. A.
10.1101/2020.04.17.20057125 — Posted: 2020-04-21 Discussion: Onsite
Differential ventilation using flow control valves as a potential bridge to full ventilatory support during the COVID-19 crisis
Levin, M., Chen, M. D., Shah, A., Shah, R., Zhou, G., Kane, E., Burnett, G., Ranginwala, S., Madek, J., Gidiscin, C., Park, C., Katz, D., Salter, B., Kohli-Seth, R., Eisenkraft, J. B., Uysal, S., McCarry, M., Leibowitz, A. B., Reich, D. L.
10.1101/2020.04.14.20053587 — Posted: 2020-04-21
COVID-19-Associated Acute Disseminated Encephalomyelitis: A Case Report
Zhang, T., Rodricks, M. B., Hirsh, E.
10.1101/2020.04.16.20068148 — Posted: 2020-04-21 Discussion: Offsite
Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection
Bernard-Valnet, R., Pizzarotti, B., Anichini, A., Demars, Y., Russo, E., Schmidhauser, M., Cerruti-Sola, J., Rossetti, A. O., Du Pasquier, R.
10.1101/2020.04.17.20060251 — Posted: 2020-04-21
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19)
Zhong, M., Sun, A., Xiao, T., Yao, G., Sang, L., Zheng, X., Zhang, J., Jin, X., Xu, L., Yang, W., Wang, P., Hu, K., Zhang, D., Ge, J.
10.1101/2020.04.15.20066266 — Posted: 2020-04-21 Discussion: Onsite
Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections
Bradley, B. T., Maioli, H., Johnston, R., Chaudhry, I., Fink, S. L., Xu, H., Najafian, B., Marshall, D., Lacy, J. M., Williams, T., Yarid, N.
10.1101/2020.04.17.20058545 — Posted: 2020-04-21
Interim evaluation of emergency declaration in Japan in the first week of the COVID-19 outbreak
Kurita, J., Sugawara, T., Ohkusa, Y.
10.1101/2020.04.16.20067447 — Posted: 2020-04-21
The effect of inter-city travel restrictions on geographical spread of COVID-19: Evidence from Wuhan, China
Quilty, B. J., Diamond, C., Liu, Y., Gibbs, H., Russell, T. W., Jarvis, C. I., Prem, K., Pearson, C. A. B., Clifford, S. J., Flasche, S., CMMID COVID-19 working group, , Klepac, P., Eggo, R. M., Jit, M.
10.1101/2020.04.16.20067504 — Posted: 2020-04-21
Early forecasts of the evolution of the COVID-19 outbreaks and quantitative assessment of the effectiveness of countering measures.
Daddi, E., Giavalisco, M.
10.1101/2020.04.16.20067553 — Posted: 2020-04-21 Discussion: Onsite
Susceptibility and Sustainability of India against CoVid19: a multivariate approach
Ray, S., Roy, M.
10.1101/2020.04.16.20066159 — Posted: 2020-04-21 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).